Kiniksa Pharmaceuticals International (KNSA) EPS (Weighted Average and Diluted) (2021 - 2025)
Historic EPS (Weighted Average and Diluted) for Kiniksa Pharmaceuticals International (KNSA) over the last 5 years, with Q3 2025 value amounting to $0.23.
- Kiniksa Pharmaceuticals International's EPS (Weighted Average and Diluted) rose 22777.78% to $0.23 in Q3 2025 from the same period last year, while for Sep 2025 it was $0.45, marking a year-over-year increase of 44615.38%. This contributed to the annual value of -$0.6 for FY2024, which is 40236.97% down from last year.
- According to the latest figures from Q3 2025, Kiniksa Pharmaceuticals International's EPS (Weighted Average and Diluted) is $0.23, which was up 22777.78% from $0.23 recorded in Q2 2025.
- Kiniksa Pharmaceuticals International's 5-year EPS (Weighted Average and Diluted) high stood at $3.18 for Q3 2022, and its period low was -$0.72 during Q1 2021.
- Over the past 5 years, Kiniksa Pharmaceuticals International's median EPS (Weighted Average and Diluted) value was -$0.18 (recorded in 2023), while the average stood at $0.09.
- Per our database at Business Quant, Kiniksa Pharmaceuticals International's EPS (Weighted Average and Diluted) surged by 82272.73% in 2022 and then plummeted by 13456.66% in 2024.
- Kiniksa Pharmaceuticals International's EPS (Weighted Average and Diluted) (Quarter) stood at -$0.52 in 2021, then skyrocketed by 341.75% to $1.26 in 2022, then tumbled by 71.36% to $0.36 in 2023, then plummeted by 134.57% to -$0.12 in 2024, then soared by 284.83% to $0.23 in 2025.
- Its EPS (Weighted Average and Diluted) was $0.23 in Q3 2025, compared to $0.23 in Q2 2025 and $0.11 in Q1 2025.